Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Faye Naessens

Publications & Research Data

Awards & Distinctions

7 Results

2026

Ferroptosis-armed dendritic cell vaccines for glioma immunotherapy

Mariia SaviukVictoria D. TurubanovaSara De BréeSandra Van LintTeresa Mendes MaiaSimon DevosIuliia EfimovaJulie BraetLore Van OudenhoveGitta Boons et al.

A1 Journal Article in NATURE COMMUNICATIONS

2024

CX3CL1 release during immunogenic apoptosis is associated with enhanced anti-tumour immunity

Faye NaessensRobin DemuynckOlga VershininaIuliia EfimovaMariia SaviukGreet De SmetTatiana A. MishchenkoMaria V. VedunovaOlga KryskoElena Catanzaro et al.

A1 Journal Article in FRONTIERS IN IMMUNOLOGY

Cytofluorometric analysis of the maturation and activation of bone marrow-derived dendritic cells to assess immunogenic cell death

Faye NaessensIuliia EfimovaMariia SaviukDmitri Krysko

Bookchapter in Immuno-oncology and immunotherapy : part B

Enhancing anti-cancer immunity through immunogenic cell death : the role of endothelial cells in the tumor microenvironment

Faye NaessensRobin DemuynckOlga VershininaIuliia EfimovaElena CatanzaroMariia SaviukLouis Van der MeerenMaria VedunovaFrauke CoppietersMikhail Ivanchenko et al.

Immunogenicity of ferroptosis in cancer : a matter of context?

Elena CatanzaroRobin DemuynckFaye NaessensLorenzo GalluzziDmitri Krysko

A1 Journal Article in TRENDS IN CANCER

2022

In vitro veritas : from 2D cultures to organ-on-a-chip models to study immunogenic cell death in the tumor microenvironment

Dmitri KryskoRobin DemuynckIuliia EfimovaFaye NaessensOlga KryskoElena Catanzaro

A1 Journal Article in CELLS

2021

Immunogenic ferroptosis and where to find it?

Robin DemuynckIuliia EfimovaFaye NaessensDmitri Krysko

A1 Journal Article in JOURNAL FOR IMMUNOTHERAPY OF CANCER